Skip to main content
. 2016 Feb 1;12(5):1300–1310. doi: 10.1080/21645515.2015.1136040

Figure 5.

Figure 5.

Percentages of subjects with rSBA titers ≥8 and 95% CIs (error bars) at 40 months and 60 months of age (Study 7), after either 4 doses (given at 2, 4, 6 and 12/13 months of age) or 2 doses (given at 12/13 and 15 months of age) of MenACWY-CRM given to infants in Study 3, by serogroup.